Filing Details

Accession Number:
0001753926-24-000518
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-03-12 16:05:51
Reporting Period:
2024-02-21
Accepted Time:
2024-03-12 16:05:51
Original Submission Date:
2024-02-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1919246 Chromocell Therapeutics Corp CHRO () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1679440 M Ezra Friedberg C/O Chromocell Therapeutics Corporation
4400 Route 9 South, Suite 1000
Freehold NJ 07728
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-21 16,667 $6.00 545,721 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.